16,885 results match your criteria Ventricular Repair

Pulmonary Atresia with Intact Ventricular Septum: Midterm Outcomes from a Multicenter Cohort.

Pediatr Cardiol 2022 Jun 25. Epub 2022 Jun 25.

Division of Cardiology, Department of Pediatrics, Shawn Jenkins Children's Hospital, Medical University of South Carolina, Charleston, SC, USA.

Contemporary multicenter data regarding midterm outcomes for neonates with pulmonary atresia with intact ventricular septum are lacking. We sought to describe outcomes in a contemporary multicenter cohort, determine factors associated with end-states, and evaluate the effect of right ventricular coronary dependency and coronary atresia on transplant-free survival. Neonates treated during 2009-2019 in 19 United States centers were reviewed. Read More

View Article and Full-Text PDF

Stage-based approach to predict left ventricular reverse remodeling after mitral repair.

Clin Cardiol 2022 Jun 24. Epub 2022 Jun 24.

Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada.

Background: Although predictors of reverse left ventricular (LV) remodeling postmitral valve repair are critical for guiding perioperative decision-making, there remains a paucity of randomized, prospective data to support the criteria that potential predictor variables must meet.

Methods And Results: The CAMRA CardioLink-2 randomized trial allocated 104 patients to either leaflet resection or preservation strategies for mitral repair. The correlation of indexed left ventricular end-systolic volume (LVESVI), indexed left ventricular end-diastolic volume (LVEDVI), and left ventricular ejection fraction (LVEF) were tested with univariate analysis and subsequently with multivariate analysis to determine independent predictors of reverse remodeling at discharge and at 12 months postoperatively. Read More

View Article and Full-Text PDF

Successful treatment of ischaemic VSD and acute RV failure: a challenging case in the modern NHS.

Br J Cardiol 2020 29;27(1):04. Epub 2020 Jan 29.

Consultant Cardiac Surgeon, Head of Programme for Complex Aortic Surgery and Clinical Lead for Cardiac Surgery Heart Centre, John Radcliffe Hospital, Headley Way, Headington, Oxford, OX3 9DU.

A 52-year-old man, previously fit and well, presented with myocardial infarction complicated by ischaemic ventricular septal defect (VSD) and acute right ventricular failure, was successfully treated with early percutaneous coronary reperfusion, surgical VSD repair and temporary right ventricular assist device (VAD) support. This case is an example of how a modern healthcare system can successfully manage complex emergency cases, combining high levels of clinical care and medical technology. Access to temporary mechanical support played a vital role in this case. Read More

View Article and Full-Text PDF
January 2020

Transcatheter Mitral Cerclage Ventriculoplasty: From Bench to Bedside.

JACC Cardiovasc Interv 2022 Jun;15(12):1249-1263

Cardiovascular Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA. Electronic address:

Background: Transcatheter mitral valve repair is beneficial in patients with mitral regurgitation (MR), left ventricular dysfunction, and persistent symptoms despite maximally tolerated medical therapy.

Objectives: The aim of this study was to evaluate the safety and feasibility of transcatheter mitral cerclage ventriculoplasty in patients with MR and either heart failure with reduced ejection fraction or preserved ejection fraction and in subjects with prior edge-to-edge repair but persistent or recurrent symptomatic MR.

Methods: The National Heart, Lung, and Blood Institute Division of Intramural Research Transcatheter Mitral Cerclage Ventriculoplasty Early Feasibility Study (NCT03929913) was an investigator-initiated prospective multicenter study. Read More

View Article and Full-Text PDF

Inferior Vena Cava-Balloon Occlusion and Its Effect on the Myocardium During Endograft Deployment in the Arch.

J Endovasc Ther 2022 Jun 23:15266028221105183. Epub 2022 Jun 23.

Department of Thoracic Surgery and Vascular Diseases, Vascular Center, Skåne University Hospital, Malmö, Sweden.

Purpose: To evaluate the impact of cava balloon occlusion on the myocardium during endovascular repair of thoracic aortic pathologies.

Material And Methods: A prospective observational cohort study of 21 patients who underwent endovascular repair of aortic arch and thoracic aorta in a single tertiary referral center with use of inferior vena cava (IVC) balloon occlusion as a method of intraoperative cardiac output reduction. Pre-, intra-, and postoperative measurements of heart rate, blood pressure, stroke volume index, and central venous oxygen saturation were noted. Read More

View Article and Full-Text PDF

Triple patch technique to repair ventricular septal rupture.

Ann Cardiothorac Surg 2022 May;11(3):273-280

Department of Cardiovascular Surgery, Tachikawa Medical Center, Nagaoka, Japan.

Postinfarction ventricular septal rupture (VSR) remains an important and life-threatening complication of myocardial infarction (MI). Although several techniques have improved surgical outcomes of postinfarction VSR, the treatment is still challenging with a high mortality rate. In addition, it is well known that a postoperative residual shunt after VSR repair is associated with poor outcomes; however, late outcomes involving patients with a residual shunt after VSR repair are lacking. Read More

View Article and Full-Text PDF

Surgical management for mechanical complications of acute myocardial infarction: a systematic review of long-term outcomes.

Ann Cardiothorac Surg 2022 May;11(3):239-251

Division of Cardiovascular Surgery, University of Florida, Gainesville, FL, USA.

Background: Mechanical complications following acute myocardial infarction (AMI), though rare, are associated with significant morbidity and mortality. Surgical management remains a mainstay of therapy for these complications. The purpose of this review is to evaluate long-term outcomes data of surgical management for postinfarction free wall rupture, ventricular septal defect, papillary muscle rupture, and pseudoaneurysm. Read More

View Article and Full-Text PDF

Mitral valve repair in papillary muscle rupture.

Ann Cardiothorac Surg 2022 May;11(3):281-289

Department of Cardiothoracic Surgery, Maastricht University Medical Centre, Maastricht, The Netherlands.

Papillary muscle rupture (PMR) is a significant mechanical complication following myocardial infarction (MI), a condition associated with a high mortality. It results in severe mitral valve regurgitation (MR), often accompanied by cardiogenic shock and pulmonary edema, requiring both emergent medical treatment and surgical intervention. Surgical treatment includes either chordal sparing mitral valve replacement or mitral valve repair, which is associated with a high mortality. Read More

View Article and Full-Text PDF

Sutureless repair of subacute left ventricular free wall rupture.

Ann Cardiothorac Surg 2022 May;11(3):299-303

Department of Cardiac Surgery, Rambam Medical Center, Haifa, Israel.

Left ventricular free wall rupture (LVFWR) is one of the most lethal heart conditions where mortality rates reach 40% intraoperatively and 80% in hospital. A few days after the acute event, the rupture becomes subacute, and surgery is indicated to repair the frail myocardium. Despite the lack of strong evidence to support the efficacy of sutureless repair of subacute LVFWR in the literature, this technique has recently been gaining popularity with acceptable success rates. Read More

View Article and Full-Text PDF

Surgical ventricular reconstruction for ischemic cardiomyopathy-a systematic review and meta-analysis of 7,685 patients.

Ann Cardiothorac Surg 2022 May;11(3):226-238

Division of Cardiac Surgery, Thomas Jefferson University, Philadelphia, PA, USA.

Background: Surgical ventricular reconstruction (SVR) has been used to control adverse ventricular remodeling and improve cardiac function in ischemic cardiomyopathy. The purpose of this systematic review and meta-analysis was to collect and analyze all available evidence on the utilization and efficacy of SVR.

Methods: An electronic database search was performed to identify all retrospective and prospective studies on SVR for ischemic cardiomyopathy in the English literature from 2000 through 2020. Read More

View Article and Full-Text PDF

Left ventricular pseudoaneurysm: the niche of post-infarction mechanical complications.

Ann Cardiothorac Surg 2022 May;11(3):290-298

Department of Cardiothoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, The Netherlands.

Left ventricular pseudoaneurysm (LVP) is a very rare, but potentially lethal mechanical complication of acute myocardial infarction (AMI). Despite representing a unique subset of cardiac rupture, it presents peculiar features that distinguish it from both ventricular free-wall rupture (FWR) and ventricular true aneurysm. LVP occurs in less than 0. Read More

View Article and Full-Text PDF

Sutureless repair techniques for post-infarction left ventricular free wall rupture.

Homare Okamura

Ann Cardiothorac Surg 2022 May;11(3):268-272

Department of Cardiovascular Surgery, Nerima Hikarigaoka Hospital, Tokyo, Japan.

Left ventricular free wall rupture after acute myocardial infarction is uncommon but lethal and is still associated with high mortality rates. This paper presents the surgical treatment options and clinical management for post-infarction left ventricular free wall rupture. Various types of techniques, specifically sutureless repair using TachoComb/TachoSil, and intraoperative video images are discussed. Read More

View Article and Full-Text PDF

Extended sandwich patch technique to repair ventricular septal rupture.

Ann Cardiothorac Surg 2022 May;11(3):337-339

Division of Cardiovascular Surgery, Shiga University of Medical Science, Otsu, Japan.

View Article and Full-Text PDF

Emergent repair of post myocardial infarction ventricular septal defect with prophylactic left ventricular assist device.

Ann Cardiothorac Surg 2022 May;11(3):343-345

Division of Cardiac Surgery, Department of Surgery, Western University, London Health Sciences Center, London, ON, Canada.

View Article and Full-Text PDF

Pre- and post-operative mechanical circulatory support in surgical repair of post-acute myocardial infarction mechanical complications.

Ann Cardiothorac Surg 2022 May;11(3):304-309

The University of Texas Health Science Center at Houston, Houston, TX, USA.

The outcomes of patients with acute myocardial infarctions (AMI) have significantly improved with advances in early reperfusion strategies; however, patients with massive infarcts or those who do not receive timely revascularization may develop mechanical complications of AMI. The most common mechanical complications are ventricular septal rupture (VSR), acute mitral regurgitation (MR) due to papillary muscle rupture, and free-wall rupture. Each complication is associated with a high risk of morbidity and mortality, and requires a multidisciplinary approach for prompt diagnosis and hemodynamic stabilization. Read More

View Article and Full-Text PDF

Surgical repair of post-infarction ventricular free-wall rupture in the Netherlands: data from a nationwide registry.

Ann Cardiothorac Surg 2022 May;11(3):310-318

Department of Cardiothoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, The Netherlands.

Background: Ventricular free-wall rupture (VFWR) is an infrequent but catastrophic complication of acute myocardial infarction (AMI). Most reports about outcome after surgical treatment are single-center experiences. We examined the early and mid-term outcomes after surgical repair of post-AMI VFWR using the Netherlands Heart Registration (NHR) database. Read More

View Article and Full-Text PDF

Tumor endothelial marker 1 is upregulated in heart after cardiac injury and participates in cardiac remodeling.

Sci Rep 2022 Jun 22;12(1):10532. Epub 2022 Jun 22.

Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, 138 Sheng Li Road, Tainan, 704, Taiwan.

Tumor endothelial marker 1 (TEM1) is a transmembrane glycoprotein that appears on mesenchymal lineage-derived cells during embryogenesis, but its expression greatly reduces after birth. Re-upregulation of TEM1 is found in tumor angiogenesis, organ fibrosis and wound healing indicating its potential role in tissue remodeling and repair. The expression level and function of TEM1 in adult heart are unknown. Read More

View Article and Full-Text PDF

Intravenously transplanted mesenchymal stromal cells: a new endocrine reservoir for cardioprotection.

Stem Cell Res Ther 2022 Jun 17;13(1):253. Epub 2022 Jun 17.

Nankai University School of Medicine, 94 Weijin Road, Tianjin, 300071, China.

Background: Intravenous administration of mesenchymal stromal cells (MSCs) has an acknowledged competence of cardiac repair, despite a lack of systematic description of the underlying biological mechanisms. The lung, but not the heart, is the main trapped site for intravenously transplanted MSCs, which leaves a spatial gap between intravenously transplanted MSCs and the injured myocardium. How lung-trapped MSCs after intravenous transplantation rejuvenate the injured myocardium remains unknown. Read More

View Article and Full-Text PDF

Invasive Hemodynamic Assessment and Procedural Success of Transcatheter Tricuspid Valve Repair-Important Factors for Right Ventricular Remodeling and Outcome.

Front Cardiovasc Med 2022 2;9:891468. Epub 2022 Jun 2.

Division of Cardiology, Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria.

Introduction: Severe tricuspid regurgitation (TR) is a common condition promoting right heart failure and is associated with a poor long-term prognosis. Transcatheter tricuspid valve repair (TTVR) emerged as a low-risk alternative to surgical repair techniques. However, patient selection remains controversial, particularly regarding the benefits of TTVR in patients with pulmonary hypertension (PH). Read More

View Article and Full-Text PDF

Notopterol Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rat.

Front Cardiovasc Med 2022 3;9:859422. Epub 2022 Jun 3.

Department of Cardiac Surgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Introduction: Current targeted pulmonary arterial hypertension (PAH) therapies have improved lung hemodynamics, cardiac function, and quality of life; however, none of these have reversed the ongoing remodeling of blood vessels. Considering notopterol, a linear furocoumarin extracted from the root of traditional Chinese medicine Qiang-Huo (), had shown the antiproliferative and anti-inflammatory properties in previous studies, we hypothesized that it could play a role in ameliorating PAH.

Methods: , we conducted monocrotaline (MCT) induced PAH rats and treated them with notopterol for 3 weeks. Read More

View Article and Full-Text PDF

A poor outcome in non-occlusive thrombo-embolic limb ischaemia related to the dislocation of mural thrombus from an abdominal aortic aneurysm.

BMC Cardiovasc Disord 2022 Jun 18;22(1):277. Epub 2022 Jun 18.

Division of NeuroSurgery, Department of Surgery, Chang Gung Memorial Hospital, Linkou, Chang Gung University, Taoyuan, Taiwan.

Background: Acute thrombosis of an abdominal aortic aneurysm with acute limb ischaemia is an unusual complication and is associated with high mortality. Dislocation of the intrasaccular mural thrombus could be one of the mechanisms. For the most part, acute limb ischaemia presents with absent pulses, compatible with the clinical findings, which include pain, paraesthesia, and paralysis. Read More

View Article and Full-Text PDF

Multi-spectrum robotic cardiac surgery: Early outcomes.

JTCVS Tech 2022 Jun 19;13:74-82. Epub 2022 Feb 19.

Department of Cardiothoracic Surgery, University of Chicago Medicine, Chicago, Ill.

Objective: The robotic cardiac surgery program at our current institution began in 2013 with an experienced and dedicated team. This review analyzes early outcomes in the first 1103 patients.

Methods: We reviewed all robotic procedures between July 2013 and February 2021. Read More

View Article and Full-Text PDF

Surgical management of delayed-presentation diaphragm hernia: A single-institution experience.

JTCVS Tech 2022 Jun 20;13:263-269. Epub 2022 Apr 20.

Division of Thoracic and Foregut Surgery, Department of Surgery, University of Minnesota, Minneapolis, Minn.

Objectives: Delayed-presentation diaphragm hernias are uncommon, and surgical management varies widely across practices. We describe our surgical experience with delayed-presentation diaphragm hernias as a case series of 14 patients, 9 of whom underwent minimally invasive repair.

Methods: We performed a retrospective chart review of our prospective database of all patients treated surgically for delayed-presentation diaphragm hernia at our institution from January 1, 2005, to April 30, 2021. Read More

View Article and Full-Text PDF

Treatment of secondary mitral regurgitation by transcatheter edge-to-edge repair using MitraClip.

J Med Ultrason (2001) 2022 Jun 16. Epub 2022 Jun 16.

Department of Cardiology, Dokkyo Medical University Saitama Medical Center, Minamikoshigaya 2-1-50, Koshigaya, Saitama, 343-8555, Japan.

Transcatheter edge-to-edge repair (TEER) is becoming the standard invasive treatment for ventricular functional mitral regurgitation (MR). It is necessary to determine the severity of MR before treatment with MitraClip; however, the severity of secondary MR is usually underestimated compared with that of primary MR and varies temporally. Therefore, to accurately determine the severity of MR, it is important to correctly use the algorithm of the guidelines for valvular heart disease and aggressively perform stress echocardiography. Read More

View Article and Full-Text PDF

Concomitant surgical revascularization in postinfarction ventricular septal rupture and ventricular aneurysm repair: A straightforward indication or a prognostic factor?

J Card Surg 2022 Jun 15. Epub 2022 Jun 15.

Department of Cardiothoracic Surgery, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, The Netherlands.

View Article and Full-Text PDF

Systematic Mapping of Conduction Tissue Regions During Congenital Heart Surgery.

Ann Thorac Surg 2022 Jun 11. Epub 2022 Jun 11.

Nora Eccles Harrison Cardiovascular Research and Training Institute, University of Utah, Salt Lake City, Utah; Department of Biomedical Engineering, University of Utah, Salt Lake City, Utah.

Purpose: Damage to cardiac conduction system is a major risk of congenital cardiac surgery. Localization of conduction system is commonly based on anatomical landmarks which are variable in congenital heart diseases. We introduce a novel technique for identification of conduction tissue regions based on real-time fiberoptic confocal microscopy (FCM). Read More

View Article and Full-Text PDF

Magnetic Resonance Imaging Assessment of Right Ventricular Deformation in Patients With Transposition of the Great Arteries.

J Thorac Imaging 2022 Jun 14. Epub 2022 Jun 14.

University of Zagreb School of Medicine.

Purpose: To detect changes of right ventricular (RV) myocardial deformation in patients with systemic RV (SRV) and transposition of the great arteries (TGA) as compared with individuals without structural heart disease.

Materials And Methods: We performed a retrospective analysis of cine steady-state free precession cardiac magnetic resonance imaging sequences acquired using a 1.5 T scanner in short-axis and long-axis views in 25 patients with SRV (16 with atrial switch repair for D-TGA and 9 with congenitally corrected TGA; age range 19 to 68, 13 males). Read More

View Article and Full-Text PDF

Outcome of patients with double valve surgery between 2009 and 2018 at University Hospital Basel, Switzerland.

J Cardiothorac Surg 2022 Jun 13;17(1):152. Epub 2022 Jun 13.

University of Basel, 4051, Basel, Switzerland.

Background: In isolated mitral valve regurgitation general consensus on surgery is to favor repair over replacement excluding rheumatic etiology or endocarditis. If concomitant aortic valve replacement is performed however, clinical evidence is more ambiguous and no explicit guidelines exist on the choice of mitral valve treatment. Both, double valve replacement (DVR) and aortic valve replacement in combination with concomitant mitral valve repair (AVR + MVP) have been proven to be feasible procedures. Read More

View Article and Full-Text PDF

A Rare Case of Post-Mitral Valve Replacement Ventricular Pseudoaneurysm, Bioprosthetic Dehiscence, and Paravalvular Mitral Regurgitation.

JACC Case Rep 2022 Apr 6;4(7):449-454. Epub 2022 Apr 6.

Mark Taper Imaging Center, Cedars Sinai Medical Center, Los Angeles, California, USA.

We present a rare case of a young patient who underwent a bioprosthetic mitral valve replacement and subsequently experienced a left ventricular pseudoaneurysm complicated by valve dehiscence and paravalvular mitral regurgitation, demonstrated by multimodality imaging and confirmed during surgical repair. (). Read More

View Article and Full-Text PDF

Diaphragmatic Hernia in a Preterm with Congenital Heart Defects with Successful Outcome: A Case Report.

JNMA J Nepal Med Assoc 2022 Jun 1;60(250):565-568. Epub 2022 Jun 1.

Neonatology Unit, Department of Pediatrics, Kathmandu Medical College and Teaching Hospital, Sinamangal, Kathmandu, Nepal.

Congenital diaphragmatic hernia is an anatomical defect of the diaphragm that is often associated with serious cardiopulmonary complications. It can also be associated with many other problems like multi systemic anomalies, chromosomal aneuploidy and prematurity. Of these, cardiac defects, liver herniation and prematurity seem to have a pivotal role in affecting the outcomes of repair. Read More

View Article and Full-Text PDF